PANEL DISCUSSION Clear Skies or Stormy Seas: Sailing the European Markets in Search of Funding & Partnerships for Effective Degrader Development
Time: 8:45 am
day: Day Two Until 10am
Details:
- What are the trends in the current European investment environment, and how can emerging companies effectively demonstrate commercial viability in these conditions?
- What is the average European life sciences VC’s risk appetite, and how can biotechs navigate this to secure investment?
- How do the dynamics of biotech-to-biotech deals compare to pharma partnerships? Does Europe need to match the more active partnering practices seen in the U.S.?
- How can biotech companies balance internal development with external partnerships, and what active decision-making criteria can they use to manage risks?
